Link Copied!
Treatments
On this page
- COVID-19 Guidelines Dashboard
- Overview by Severity
- Corticosteroids
- Recommendations
- Dosing
- Antivirals
- Remdesivir
- Other Antivirals
- Antibodies
- Monoclonal Antibodies
- Convalescent Plasma
- Immunomodulators
- Anti-IL-6 Agents (e.g. Tocilizumab)
- JAK Inhibitors (e.g. Baricitinib)
- Anti-IL-1 Agents (e.g. Anakinra)
- Symptomatic Treatments
- Cough
- Dyspnea
- Pain
- Anxiety
- Respiratory Secretions
- Nausea and Vomiting
- Delirium
- Anticoagulation
- Prophylactic Dosing
- Therapeutic Dosing
- Aspirin
- Antibiotics
- Choice of Antibiotics
- Treatments for Comorbid Diseases
- RAAS Inhibitors
- Statins
- Calcium Channel Blockers
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Bronchodilators
- Blood Products
- Immunosuppressants
- Other Miscellaneous Agents
- Hydroxychloroquine
- Azithromycin
- Ivermectin
- Nitazoxanide
- Famotidine
- Zinc
- Vitamin C
- Clinical Trials
- Baseline Immunosuppression
- COVID-19 Risk by Medication
- Management of Baseline Immunosuppression